Use of measures of disproportionality in pharmacovigilance: Three Dutch examples

Drug Safety

Volumn 25, Issue 6, 2002, Pages 453-458

  Egberts, A C G ^a,b   Meyboom, R H B ^a,c,d   Van Puijenbroek, E P ^c  

^a UTRECHT UNIVERSITY   (Netherlands)

^b GGZ Midden Brabant   (Netherlands)

^c Netherlands Pharmacovigilance Centre Lareb   (Netherlands)

^d UPPSALA MONITORING CENTRE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; DIURETIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

CONFERENCE PAPER; CONGESTIVE HEART FAILURE; COVARIANCE; DATA BASE; DRUG SURVEILLANCE PROGRAM; HUMAN; LACTATION; NETHERLANDS; PRIORITY JOURNAL; SIDE EFFECT; SIGNAL DETECTION;

EID: 0036303879     PISSN: 01145916     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002018-200225060-00010     Document Type: Conference Paper

References (21)

1. Principles of signal detection in pharmacovigilance
2. Adverse drug reactions: Definitions, diagnosis, and management
3. The design and logic of a monitor of drug use
4. Statisical logic in the monitoring of reactions to therapeutic drugs
5. Serum sickness-like reactions to cefaclor
6. Proportional reporting ratios: The uses of epidemiological methods for signal generation
7. Transformation of a database of spontaneously reported suspected adverse drug reactions and its use as a tool in signal detection
8. Pharmacovigilance: A science or fielding emergencies?
9. Reports of hypoglycaemia associated with the use of ACE inhibitors and other drugs: A case/non-case study in the French pharmacovigilance system database
10. Power and weakness of spontaneous reporting: A probabilistic approach
11. A Bayesian neural network method for adverse drug reaction signal generation
12. From association to alert: A revised approach to international signal analysis
13. A retrospective evaluation of a data mining approach to aid finding new adverse drug reaction signals in the WHO international database
14. Bayesian data mining in large frequency tables, with an application to the FDA spontaneous reporting system
15. Non-puerperal lactation associated with antidepressant drug use
16. Signalling possible drug-drug interactions in a spontaneous reporting system: Delay of withdrawal bleeding during concomitant use of oral contraceptives and itraconazole
17. Association between terbinafine and arthralgia, fever and urticaria: Symptoms or syndrome?
18. Causal or casual: The role of causality assessment in pharmacovigilance
19. Non-sedating antihistamine drugs and cardiac arrhytmias: Biased risk estimates from spontaneous reporting systems?
20. A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions